What Cancers are Treated with Checkpoint Inhibitors?
Checkpoint inhibitors have shown efficacy in treating a variety of cancers. Melanoma, non-small cell lung cancer (NSCLC), renal cell carcinoma (kidney cancer), and Hodgkin lymphoma are some of the cancers that have responded well to these therapies. The success of checkpoint inhibitors in these cancers has led to ongoing research and clinical trials for other malignancies.
